Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Wednesday they had finalized plans to ...

Alexander Malyshev and Sarah Ganley of Carter Ledyard & Milburn LLP discuss a gray area when the 2018 Farm Bill legalized ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

The justices said they were not ruling on the legality of specific firing plans but simply allowing the administration to ...

Looming threats to pharmaceuticals and the drug supply chain have brought fresh attention to onshoring. Experts say ...

One of the nation's largest candy makers is pushing back on a years-long effort to remove artificial food dyes from its ...

In addition to finding these dyes in brightly colored processed foods, the researchers also found them in more muted foods ...

Publix has had to manage several recalls involving both meat and non-meat products since the start of the year.

The fact that lenacapavir will soon be available to patients is a testament to the strength of America's biopharmaceutical ...

The steady erosion of experienced staff at the Food and Drug Administration is slowly compromising the agency’s work, current ...

The company had blamed FDA "resource constraints" for the delay, while a rival drug for hereditary angioedema received an ...

Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Wednesday they had finalised plans to ...